Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer

Until recently, continuing androgen deprivation therapy (ADT) and closely monitoring patients until evolution towards metastatic castration-resistant prostate cancer (CRPC) were recommended in men with non-metastatic CRPC (nmCRPC). Because delaying the development of metastases and symptoms in these...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavaud, Pernelle, Dumont, Clément, Thibault, Constance, Albiges, Laurence, Baciarello, Giulia, Colomba, Emeline, Flippot, Ronan, Fuerea, Alina, Loriot, Yohann, Fizazi, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768840/
https://www.ncbi.nlm.nih.gov/pubmed/33488778
http://dx.doi.org/10.1177/1758835920978134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768840/
https://www.ncbi.nlm.nih.gov/pubmed/33488778
http://dx.doi.org/10.1177/1758835920978134

Ejemplares similares